Clinical Trial Update: Predicting 28-Day Mortality in Subarachnoid Hemorrhage

View source ↗

Summary

Completed clinical trial evaluating a prognostic model for predicting 28-day mortality in aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Status: COMPLETED